Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.
Clinical trial NCT05515042 · UNKNOWN
Trial details
- NCT number
- NCT05515042
- Sponsor
- The Aurum Institute NPC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2024-06-30
- Enrollment
- 694
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.